share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Hoge Stephen

SEC announcement ·  Mar 5 17:54
Summary by Moomoo AI
Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of 309 shares of common stock on 03/04/2024. The transaction was executed at a price of $94.3383 per share, resulting in a total market value of $29,150.53. This sale followed an acquisition of 652 shares through the exercise of derivative securities on 03/01/2024. After these transactions, Hoge's direct holdings in Moderna amount to 1,516,241 shares. Additionally, Hoge has indirect beneficial ownership of 156,049 shares through entities such as Valhalla, LLC and a Trust.
Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of 309 shares of common stock on 03/04/2024. The transaction was executed at a price of $94.3383 per share, resulting in a total market value of $29,150.53. This sale followed an acquisition of 652 shares through the exercise of derivative securities on 03/01/2024. After these transactions, Hoge's direct holdings in Moderna amount to 1,516,241 shares. Additionally, Hoge has indirect beneficial ownership of 156,049 shares through entities such as Valhalla, LLC and a Trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more